Pancreatic Cancer Research

ResearcherCold Spring Harbor LaboratoryActive in the last 2 years

Tim D.D. Somerville

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6295-6126; OpenAlex author ID A5044983315. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
42
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 4 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 9

  1. Dynamic Evolution of Fibroblasts Revealed by Single-Cell RNA Sequencing of Human Pancreatic Cancer. Co-author DOI 10.1158/2767-9764.crc-23-0489↗
  2. p73 activates transcriptional signatures of basal lineage identity and ciliogenesis in pancreatic ductal adenocarcinoma First author DOI 10.1101/2023.04.20.537667↗
  3. ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer. Co-author DOI 10.1073/pnas.1921484117↗
  4. SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. Co-author DOI 10.1084/jem.20192389↗
  5. Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes. Co-author DOI 10.1158/2159-8290.cd-20-0133↗
  6. Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation. Co-author DOI 10.7554/elife.53381↗
  7. TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.celrep.2018.10.051↗
  8. Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-18-0349↗
  9. Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis. Co-author DOI 10.1016/j.cell.2017.07.007↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christopher R. Vakoc · 7 shared papers, 2017–2023 · strength 0.69
  2. David Arthur Tuveson · 6 shared papers, 2017–2023 · strength 0.58
  3. Diogo Maia-Silva · 4 shared papers, 2018–2023 · strength 0.48
  4. Stella K. Hur · 3 shared papers, 2020–2023 · strength 0.40
  5. Koji Miyabayashi · 4 shared papers, 2017–2020 · strength 0.30
  6. Faiyaz Notta · 2 shared papers, 2020–2023 · strength 0.27
  7. Chang‐Il Hwang · 3 shared papers, 2017–2020 · strength 0.21
  8. Youngkyu Park · 3 shared papers, 2017–2020 · strength 0.21
  9. Hervé Tiriac · 3 shared papers, 2017–2020 · strength 0.21
  10. Giulia Biffi · 2 shared papers, 2020 · strength 0.18
  11. Lindsey A. Baker · 2 shared papers, 2020 · strength 0.16
  12. Mikala Egeblad · 2 shared papers, 2017–2020 · strength 0.14
  13. Michael Anthony Hollingsworth · 2 shared papers, 2017–2020 · strength 0.14
  14. David Tsai Ting · 1 shared paper, 2024 · strength 0.14
  15. Carlos F. Fernandez-del Castillo · 1 shared paper, 2024 · strength 0.14
  16. Andrew Louis Warshaw · 1 shared paper, 2024 · strength 0.14
  17. Viviana Cremasco · 1 shared paper, 2024 · strength 0.14
  18. Slavica Dimitrieva · 1 shared paper, 2024 · strength 0.14
  19. Mari A. Mino-Kenudson · 1 shared paper, 2024 · strength 0.14
  20. Jon Michael Harrison · 1 shared paper, 2024 · strength 0.14
  21. Jeffrey A. Engelman · 1 shared paper, 2024 · strength 0.14
  22. Motaz Qadan · 1 shared paper, 2024 · strength 0.14
  23. Cristina Rosa Ferrone · 1 shared paper, 2024 · strength 0.14
  24. Andrew Scott Liss · 1 shared paper, 2024 · strength 0.14
  25. Keith D. Lillemoe · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.